ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

House Subcommittee voted $1.011 Billion For NCU 1981 Fiscal Year Budget In Closed Door Meeting

August 8, 1980

FDA Approves Afinitor Tablets For Advanced Breast Cancer

August 31, 2012

Bone Marrow Transplant Survival Has Doubled In Young Patients

August 26, 2011

Pancreatic Cancer Research To Increase, Institute Says.

November 16, 2001

ACC Will Develop Standards, Patient Management Guidelines To Upgrade Community Cancer Programs

March 23, 1984

NCI Buys Building For PDQ, ICRDB With Donated Money

December 10, 1982